The project is part of the 1. Public contest for industrial and experimental development program TREND organized by TAČR. It took the 11. place amongst all 396 projects submitted in this contest. The project will be scheduled for 4 years and it was started in 2020.
The consortium was established upon the previous long-term cooperation of all the incorporated companies.
Advacam s.r.o. is the leader of the project, it experienced several successfully finished projects in the past not only in Czech Republic, but in international scale as well. ADVACAM is responsible for the part dedicated to the development of the detectors and advanced imaging methods.
ThyroPIX will bring an efficient instrument to meet the 2018/02 implemented EU ordinance 2013/59/EURATOM requirements on radiation therapy planning and verification which is problematical in nuclear medicine methods.
The major concern in design and development will be payed to elimination of known limitations and disadvantages which prevents the therapeutic centers to meet the requirements of the legislations which will consequently enable to apply principals of personalized medicine in administrations of the therapeutic radio-pharmaceuticals.
Radalytica a.s. is going to integrate the imaging system into the final solution within developing the control software and imaging software.
Advacam is developing imaging solutions for industrial and academic needs.
Czech Metrology Institut will do Monte Carlo simulations and imaging methodology.
First Faculty of Medicine of Charles University, Center of advanced preclinical imaging will do preclinical tests on small animals.
Clinic of nuclear medicine and endocrinology will do clinical tests on human patients.
1. mobile base with IT and peripheries for robot motion control and acquisition parameters setting
2. robotic arm Universal Robots UR5 with safety sensors and optical system
3. hybrid pixel detector for photons detection